1-8 of 8
Angelica Loskog
Close
Sort by
Journal Articles

Marked Impact of Different Cytokines on Phenotype and Cytotoxic Activity of CD19-Specific CAR T Cells

Jean-Marc Hoffmann, Lei Wang, Angela Hückelhoven, PhD, Anita Schmitt, MD, Ulrike Gern, Leopold Sellner, MD, Christian Kleist, PhD, Jessica Wenthe, Patrick Wuchter, MD, Maria-Luisa Schubert, MD, Hyeon Joo Yoo, Ming Ni, Susanne Hofmann, MD, Peter Dreger, MD, Anthony D. Ho, MD, Angelica Loskog, PhD, Michael Schmitt, MD
Journal: Blood
Blood (2016) 128 (22): 3509.
https://doi.org/10.1182/blood.V128.22.3509.3509
Published: 2016
Journal Articles

Increased TACE (Tumor necrosis factor-alpha±-converting enzyme; ADAM17) Activity Associates with Decreased CD62L Expression, Increased Soluble CD62L Plasma Levels and Predicts Molecular Response to Nilotinib Therapy in Patients with Early Chronic Phase Chronic Myelogenous Leukemia (CML-CP): Results from an ENEST1st Substudy

Sieghart Sopper, PhD, Satu Mustjoki, MD PhD, Angelica Loskog, PhD, Bjorn T. Gjertsen, MD PhD, Guenther A. Gastl, MD, Frank Giles, MDMB, Andreas Hochhaus, MD, Gert J. Ossenkoppele, MD PhD, Kimmo Porkka, MD PhD, Dominik Wolf, MD
Journal: Blood
Blood (2015) 126 (23): 4033.
https://doi.org/10.1182/blood.V126.23.4033.4033
Published: 2015
Journal Articles

Third Generation CD19-CAR T Cells for Relapsed and Refractory Lymphoma and Leukemia Report from the Swedish Phase I/IIa Trial

Gunilla Enblad, MDPhD, Hannah Karlsson, PhD, Kristina Wikstrom, PhD, Magnus Essand, PhD, Barbara Savoldo, MD PhD, Malcolm K. Brenner, MD PhD, Gianpietro Dotti, MD, Helene Hallbook, MDPhD, Martin Hoglund, MD PhD, Hans Hagberg, MD PhD, Angelica Loskog, PhD
Journal: Blood
Blood (2015) 126 (23): 1534.
https://doi.org/10.1182/blood.V126.23.1534.1534
Published: 2015
Journal Articles

Reduced Expression of CD62L Is Associated with Increased ADAM17 Activity and Predicts Molecular Response to Nilotinib Therapy in Patients with Early Chronic Phase Chronic Myelogenous Leukemia (CML-CP)

Sieghart Sopper, PhD, Satu Mustjoki, MD PhD, Angelica Loskog, PhD, Bjorn T. Gjertsen, MD PhD, Ute Mark, Jens Haenig, Nidas Jurjonas, Gunther Gastl, Prof., Dr., Frank Giles, MDMB, Andreas Hochhaus, MD, Gert J Ossenkoppele, MD PhD, Kimmo Porkka, MD PhD, Dominik Wolf, MD
Journal: Blood
Blood (2014) 124 (21): 4522.
https://doi.org/10.1182/blood.V124.21.4522.4522
Published: 2014
Journal Articles

Immune Monitoring In Patients With Early Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Treated With Frontline Nilotinib

Sieghart Sopper, PhD, Satu Mustjoki, MD, PhD, Angelica Loskog, PhD, Bjorn T Gjertsen, MD PhD, Richard Greil, MD, Alois Lang, MD, Werner Linkesch, MD, Josef Thaler, MD, Tobias Gedde-Dahl, III, MD, PhD, Henrik Hjorth-Jansen, MD, Waleed Majeed, MD, Kourosh Lofti, MD, PhD, Johan Richter, MD, PhD, Sören Lehman, MD, Leif Stenke, MD, PhD, Ulla Olsson-Strömberg, MD, PhD, Jesper Stentoft, MD, Ward Posthuma, MD, PhD, Willem Smit, Edo Vellenga, MD, PhD, Gregor Verhoef, Augustin Ferrant, MD, PhD, Jan Van Droogenbroeck, MD, Ute Mark, Jens Haenig, Nidas Jurjonas, Gunther Gastl, Prof., Dr., Frank Giles, MD MB, Andreas Hochhaus, MD, Gert J. Ossenkoppele, MD PhD, Kimmo Porkka, MD, PhD, Dominik Wolf, MD
Journal: Blood
Blood (2013) 122 (21): 2731.
https://doi.org/10.1182/blood.V122.21.2731.2731
Published: 2013
Journal Articles

ABT-737 Sensitizes B Cell Tumors for Killing by CD19-Retargeted T Cells,

Hannah S C Karlsson, Camilla Lindqvist, PhD, Gabriella Paul-Wetterberg, Helena Jernberg Wiklund, PhD, Kenneth Nilsson, MD, PhD, Bengt Simonsson, MD, PhD, Per Frisk, MD, PhD, Angelica Loskog, PhD
Journal: Blood
Blood (2011) 118 (21): 4032.
https://doi.org/10.1182/blood.V118.21.4032.4032
Published: 2011
Journal Articles

Increased Levels of Myeloid-Derived Suppressor Cells (MDSCs) in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on MDSCs in Vitro

Lisa H Christiansson, M.Sc, Stina Söderlund, MD, Emma Svensson, Mats Bengtsson, MD, PhD, Bengt Simonsson, MD, PhD, Ulla Olsson-Strömberg, MD, PhD, Angelica Loskog, PhD
Journal: Blood
Blood (2011) 118 (21): 2744.
https://doi.org/10.1182/blood.V118.21.2744.2744
Published: 2011
Journal Articles

Soluble IL2R (CD25), IL10 and PDL1 May Control T Cell Activation in Chronic Myeloid Leukemia.

Lisa Christiansson, Camilla Lindqvist, Thomas H Tötterman, Bengt Simonsson, Ulla Olsson-Strömberg, Angelica Loskog
Journal: Blood
Blood (2009) 114 (22): 4252.
https://doi.org/10.1182/blood.V114.22.4252.4252
Published: 2009